-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Niazinin
![{PARAM:[Name]}({[CAS]})](https://resource.bocsci.com/structure/147821-57-6.gif)
Category | SARS-CoV |
CAS | 147821-57-6 |
Description | Niazinin is a natural compound isolated from the leaves of Moringa oleifera Lam, showing antileishmanial activity against promastigotes of Leishmania donavani. |
Product Information
Synonyms | Niazinin A |
IUPAC Name | O-methyl N-[[4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyphenyl]methyl]carbamothioate |
Molecular Weight | 343.39 |
Molecular Formula | C15H21NO6S |
Canonical SMILES | CC1C(C(C(C(O1)OC2=CC=C(C=C2)CNC(=S)OC)O)O)O |
InChI | InChI=1S/C15H21NO6S/c1-8-11(17)12(18)13(19)14(21-8)22-10-5-3-9(4-6-10)7-16-15(23)20-2/h3-6,8,11-14,17-19H,7H2,1-2H3,(H,16,23)/t8-,11-,12+,13+,14-/m0/s1 |
InChIKey | ZOIAMMQYAZSWRX-CNJBRALLSA-N |
Purity | 98.0% |
Solubility | In vitro: 10 mM in DMSO |
Appearance | Oil |
Storage | 4°C, protect from light * In solvent : -80°C, 6 months -20°C, 1 month (protect from light) |
Complexity | 390 |
Exact Mass | 343.10895856 |
In Vitro | Niazinin, is cytotoxic at substantially higher concentration (CC50 of 31.6 µM) than its antileishmanial concentration (IC50 of 5.25 µM). |
Target | Parasite; SARS-CoV |
XLogP3-AA | 0.4 |